scholarly article | Q13442814 |
P2093 | author name string | LISA JR | |
ALLEN RA | |||
P2860 | cites work | The Pathology of Fatal Epidemic Hepatitis. | Q36079269 |
Primary Carcinoma of the Liver with Metastases to Bone: Report of a Case. | Q42590024 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 647-655 | |
P577 | publication date | 1949-07-01 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Combined liver cell and bile duct carcinoma | |
P478 | volume | 25 |
Q52629233 | A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma. |
Q49523608 | A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy. |
Q37205355 | A case of combined hepatocellular-cholangiocarcinoma with underlying schistosomiasis |
Q53229266 | A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma. |
Q42116369 | A case report of synchronous double primary liver cancers combined with early gastric cancer |
Q58781329 | Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report |
Q37528168 | An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. |
Q90735269 | Breast Metastasis From a Combined Hepatocellular-Cholangiocarcinoma |
Q34975197 | Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. |
Q58707841 | Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma |
Q40820874 | Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma |
Q35782193 | Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. |
Q51625972 | Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma. |
Q79914640 | Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma |
Q37675494 | Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. |
Q38408925 | Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. |
Q35176302 | Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea |
Q90476381 | Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma |
Q35832927 | Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver |
Q37856825 | Combined hepatocellular and cholangiocarcinoma associated with hepatolithiasis: report of a case. |
Q40742371 | Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. |
Q37316850 | Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia |
Q35936570 | Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography |
Q38481613 | Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation |
Q60928177 | Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions |
Q26749446 | Combined hepatocellular cholangiocarcinoma: Controversies to be addressed |
Q38080486 | Combined hepatocellular cholangiocarcinoma: a case report and review of literature |
Q35176484 | Combined hepatocellular cholangiocarcinomas; analysis of a large database |
Q58101989 | Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature |
Q90372062 | Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery |
Q64098715 | Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends |
Q89433582 | Comparing Clonality Between Components of Combined Hepatocellular Carcinoma and Cholangiocarcinoma by Targeted Sequencing |
Q80337206 | Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma |
Q64093805 | Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery |
Q42089414 | Concurrent occurrence of primary hepatocellular and cholangiocellular carcinoma in the different part of the liver: a case report. |
Q38367027 | Current update on combined hepatocellular-cholangiocarcinoma. |
Q93026734 | Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma |
Q40914145 | Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A case report |
Q37185715 | Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature |
Q40248695 | Double tumours of the liver following intravenous thorotrast injection. Patho-anatomical report on two cases |
Q35538028 | Effect of liver transplantation in combined hepatocellular and cholangiocellular carcinoma: a case series |
Q50300185 | Esophageal metastasis of stem cell-subtype hepatocholangiocarcinoma: Rare presentation of a rare tumor |
Q47423452 | Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study |
Q40086635 | Hepatoma causing a massive tumour embolus |
Q51827189 | Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series. |
Q36400904 | Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. |
Q91781075 | Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma |
Q33654745 | Importance of surgical margin in the outcomes of hepatocholangiocarcinoma |
Q36276041 | Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma |
Q35924971 | Intrahepatic cholangiocarcinoma: expert consensus statement. |
Q45270825 | Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C. |
Q98461106 | Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients |
Q36570284 | Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database |
Q72780520 | MR imaging of mixed hepatocellular and cholangiocellular carcinoma |
Q52682691 | MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. |
Q36498935 | Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review |
Q37391713 | Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics. |
Q35048768 | Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? |
Q57112805 | Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma |
Q90448474 | Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features |
Q55279869 | Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas. |
Q52655169 | Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma. |
Q35229812 | Oral contraceptives and liver disease. |
Q34127764 | Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver |
Q78450628 | PRIMARY CARCINOMA OF THE LIVER; ANALYSIS OF CLINICAL AND BIOCHEMICAL FEATURES OF 80 CASES |
Q92586385 | Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection |
Q45401124 | Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma |
Q55249804 | Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma. |
Q38408142 | Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification. |
Q38420005 | Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. |
Q48156461 | Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma |
Q47550101 | Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma |
Q35921050 | Primary carcinoma of the liver in hemochromatosis |
Q36132782 | Primary carcinomas of the liver and biliary tract |
Q34823616 | Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma |
Q54247807 | Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. |
Q89769430 | Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review |
Q37175948 | Surgical treatment of double primary liver cancer: An observational study for a rare type of tumor |
Q34390202 | Synchronous development of HCC and CCC in the same subsegment of the liver in a patient with type C liver cirrhosis |
Q37430576 | Synchronous double cancers of primary hepatocellular carcinoma and cholangiolocellular carcinoma: a case report |
Q27022499 | Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature |
Q55100898 | The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection. |
Q69507027 | The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan |
Q33610064 | The histogenesis of primary hepatic carcinoma |
Q36279142 | Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma |
Q90736364 | Treatment of Combined Hepatocellular and Cholangiocarcinoma |
Q55438928 | Two Surgical Cases of Combined Hepatocellular-Cholangiocarcinoma, Intermediate-Cell Subtype: Potentially Characteristic Gross Features. |
Q37605862 | Uncommon liver tumors: Case report and literature review |
Q54985330 | Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. |
Search more.